[CYCC] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
30-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -0.75%
YoY- 34.10%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 0 0 150 0 277 424 247 -
PBT -3,182 -2,752 -2,370 -2,071 -3,249 -3,872 -5,907 -9.78%
Tax -378 -449 -352 -200 -409 -498 -1,108 -16.39%
NP -2,804 -2,303 -2,018 -1,871 -2,839 -3,374 -4,799 -8.55%
Tax Rate - - - - - - - -
Total Cost 2,804 2,303 2,168 1,871 3,116 3,798 5,046 -9.32%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -47,711,417,389,824.74 0.00 -1,345.33 0.00 -1,024.91 -795.75 -1,942.91 5271.73%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -0.57 -2.68 -2.96 -3.14 -13.34 -23.15 -50.11 -52.54%
EPS Diluted -0.57 -2.68 -2.96 -3.12 -13.34 -23.15 -50.11 -52.54%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.